Logo

CME

CME Group Inc.

CME

CME Group Inc. • NASDAQ
$281.46 ▲ 0.21% (+0.59)
Market Cap $101.49 B
52w High $290.79
52w Low $224.62
Dividend Yield 5.00%
P/E 27.25
Volume 726.30K
Outstanding Shares 360.60M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $1.538B ▼ $327.4M ▼ $908M ▼ 59.053% ▼ $2.49 ▼ $1.304B ▼
Q2-2025 $1.692B ▲ $341.1M ▲ $1.012B ▲ 59.823% ▲ $2.81 ▲ $1.458B ▲
Q1-2025 $1.642B ▲ $327.6M ▼ $956.2M ▲ 58.223% ▲ $2.63 ▲ $1.369B ▲
Q4-2024 $1.525B ▼ $357.4M ▲ $874.6M ▼ 57.34% ▼ $2.4 ▼ $1.221B ▼
Q3-2024 $1.584B $341.4M $912.8M 57.612% $2.51 $1.301B

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $2.576B ▲ $187.145B ▲ $158.954B ▲ $28.19B ▲
Q2-2025 $2.099B ▲ $179.907B ▲ $152.168B ▲ $27.739B ▲
Q1-2025 $1.519B ▼ $157.832B ▲ $130.801B ▲ $27.031B ▲
Q4-2024 $3.006B ▲ $137.447B ▼ $110.96B ▲ $26.487B ▼
Q3-2024 $2.434B $137.795B $109.579B $28.216B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $908M ▼ $968.1M ▼ $-19.1M ▼ $6.4B ▼ $465.5M ▼ $949.7M ▼
Q2-2025 $1.025B ▲ $1.058B ▼ $-18M ▼ $20.999B ▲ $576.2M ▼ $1.04B ▼
Q1-2025 $956.2M ▲ $1.117B ▲ $-16M ▲ $19.211B ▲ $20.312B ▲ $1.102B ▲
Q4-2024 $874.6M ▼ $1.018B ▲ $-25.3M ▲ $-984.1M ▼ $8.5M ▼ $991.7M ▲
Q3-2024 $912.8M $1.003B $-29.5M $13.347B $14.32B $973.2M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
clearing and transaction fees
clearing and transaction fees
 $1.23Bn ▲$1.34Bn ▲$1.39Bn ▲$1.23Bn ▼
MarketData
MarketData
 $180.00M ▲$190.00M ▲$200.00M ▲$200.00M ▲
OtherRevenue
OtherRevenue
 $110.00M ▲$110.00M ▲$110.00M ▲$110.00M ▲

Five-Year Company Overview

Income Statement

Income Statement CME’s income statement shows a steady, healthy uptrend. Revenue has risen well over the last few years, and profits have grown even faster, which suggests strong pricing power and tight cost control. Margins remain very high for a financial services firm, reflecting the scalability of an exchange business where more volume does not require much extra cost. Earnings per share have climbed consistently, helped by both higher profits and operating leverage. The main risk is that results are sensitive to trading activity and volatility, which can fluctuate with market conditions and regulation.

Balance Sheet

Balance Sheet The balance sheet looks solid and relatively conservative. Debt levels have been stable for years and appear manageable relative to the company’s earnings strength. Reported total assets have moved around quite a bit, which is common for a clearinghouse business where client collateral flows on and off the balance sheet. Equity has stayed broadly steady, suggesting CME is not highly leveraged and has a decent capital cushion. Overall, the financial position supports resilience through market cycles, though the business is still tied to broader financial-system stability.

Cash Flow

Cash Flow CME converts a large portion of its accounting profits into cash, which is a key strength. Operating cash flow has trended upward over time, broadly in line with earnings growth. Capital spending needs are modest, so free cash flow remains very strong and close to operating cash flow. This cash flexibility gives CME room to invest in technology, return cash to shareholders, and manage debt without stretching its finances. The main watchpoint is that cash generation, like earnings, would cool if trading volumes materially declined for an extended period.

Competitive Edge

Competitive Edge CME holds a dominant position in global derivatives, especially in core interest rate and equity index contracts, where liquidity is deepest. Its network effects are powerful: traders go where the liquidity is, and that liquidity is hard for new entrants to replicate. The company’s large and diverse product lineup across asset classes makes it a central hub for risk management worldwide, and its clearinghouse adds an extra layer of stickiness and trust. Established competitors like ICE and newer challengers like FMX are trying to chip away at select products, but CME’s entrenched liquidity and long track record give it a strong edge. The key competitive risks are regulatory changes, fee pressure, and any shift of trading to alternative venues or new technologies.

Innovation and R&D

Innovation and R&D CME’s innovation focus is less about traditional R&D labs and more about technology, product design, and partnerships. The Globex electronic platform and CME Clearing are core innovations that continue to be upgraded for speed, reliability, and risk management. The partnership with Google Cloud aims to modernize data, analytics, and cloud infrastructure, potentially creating new data products and a better client experience. CME has been early in areas like micro-futures, SOFR-based contracts, and regulated crypto futures, showing a willingness to experiment within a conservative risk framework. Future upside likely depends on expanding international reach, rolling out new data and analytics tools, growing micro and retail-oriented products, and further developing digital asset offerings as regulation evolves.

Summary

CME Group looks like a high-margin, asset-light financial infrastructure company with steady revenue growth and very strong profitability. Its balance sheet and cash flow profile are robust, giving it flexibility to invest and weather downturns. The company’s real strength lies in its entrenched competitive position: deep liquidity, a trusted clearinghouse, and a broad, globally relevant product set. At the same time, it operates in a regulated, cyclical environment where trading volumes and volatility can swing, and where new competitors and changing technology are constant threats. Overall, CME appears financially resilient and strategically well positioned, with its long-term story tied to the continued central role of listed derivatives and clearing in the global financial system.

NEWS

November 24, 2025 · 12:50 PM UTC

CME Group Cryptocurrency Complex Reaches All-Time Daily Volume Record

Read more

November 24, 2025 · 11:39 AM UTC

CME Group U.S. Treasury Open Interest Hits Record of 35 Million Contracts

Read more

November 20, 2025 · 9:00 AM UTC

CME Group and CF Benchmarks to Launch CME CF Bitcoin Volatility Indices

Read more

November 18, 2025 · 5:00 PM UTC

Canadian Metals Announces Private Placement of up to $2.4 Million

Read more

November 12, 2025 · 4:05 PM UTC

FanDuel and CME Group Unveil New Prediction Markets Platform to Launch in December

Read more